Investment Stage

Focus Areas

About Investor

Simon Read is a Venture Partner at Atlas Venture based in the United States. He focuses primarily on biotech investments across pre-seed, seed, and Series A stages. His typical investment range is around $1M to $5M, with a strong preference for early scientific breakthroughs. Simon is deeply involved in evaluating novel therapeutic approaches and life sciences innovation. He often supports companies with strong academic or research-driven foundations transitioning into commercialization. His role at Atlas positions him as a strategic biotech investor with a focus on long-term scientific value creation.